Aditxt (ADTX) Share-based Compensation (2019 - 2025)
Aditxt (ADTX) recorded quarterly Share-based Compensation of $10000.0 in Q1 2025, up 100.15% quarter-over-quarter from -$6.7 million in Q4 2024, and down 59.3% on a YoY basis from $24573.0 in Q1 2024.
Aditxt (ADTX) Share-based Compensation (2019 - 2025) Analysis & Trends
Aditxt's Share-based Compensation history runs 7 years deep, the most recent figure standing at $10000.0 for Q1 2025.
- In Q1 2025, Share-based Compensation fell 59.3% year-over-year to $10000.0; the TTM figure through Dec 2025 stood at $10000.0 (up 100.15% YoY), while the FY2025 annual figure was $473311.0, up 1331.2% from the prior year.
- Share-based Compensation was $10000.0 for Q1 2025 at Aditxt, up from -$6.7 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $1.5 million in Q4 2021 to a low of -$6.7 million in Q4 2024.
- Historically, Share-based Compensation has averaged -$18545.5 across 5 years, with a median of $201613.0 in 2021.
- The sharpest annual moves came in 2021 and 2024: Share-based Compensation soared 176.69% in 2021, then tumbled 996.17% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $1.5 million in 2021, then slumped by 59.16% to $614247.0 in 2022, then gained by 21.34% to $745347.0 in 2023, then sank by 996.17% to -$6.7 million in 2024, then jumped by 100.15% to $10000.0 in 2025.
- The last three Share-based Compensation figures came in at $10000.0 (Q1 2025), -$6.7 million (Q4 2024), and $32.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | -6.68 Mn |
| Dec 31, 2024 | -6.68 Mn |
| Sep 30, 2024 | 32.00 |
| Sep 30, 2024 | 32.00 |
| Jun 30, 2024 | 4,097.00 |
| Jun 30, 2024 | 4,097.00 |
| Mar 31, 2024 | 24,573.00 |
| Mar 31, 2024 | 24,573.00 |
| Dec 31, 2023 | 745,347.00 |
| Dec 31, 2023 | 745,347.00 |
| Sep 30, 2023 | 103,031.00 |
| Sep 30, 2023 | 103,031.00 |
| Jun 30, 2023 | 107,156.00 |
| Jun 30, 2023 | 107,156.00 |
| Mar 31, 2023 | 339,451.00 |
| Mar 31, 2023 | 339,451.00 |
| Dec 31, 2022 | 614,247.00 |
| Dec 31, 2022 | 614,247.00 |